Another expansion of a local biotech - Northern Biologics, with VC and big pharma backing
Celgene, Versant back a biotech merger, building an antibody pipeline and lining up for the clinic
Versant Ventures and Celgene have extended their deal to foster a Toronto-based biotech called Northern Biologics, bringing in a Phase I-ready cancer drug through a merger with a small biotech in Barcelona and pumping in fresh funds to drive its pivot into the clinic. The Spanish biotech is called Mosaic
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.